FDA 510(k)

直接胆红素

K号: K152343 · 2016-02-16

决定日期2016-02-16

产品代码JFM

咨询委员会CH 请注意，您提供的文本“CH”不足以进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。

决定实质等同

器械摘要

Direct Bilirubin is the device name listed in this FDA 510(k) record. The listed applicant is Randox Laboratories Limited. It received FDA 510(k) clearance on 2016-02-16 under 510(k) number K152343. The device is classified under product code JFM. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Direct Bilirubin?

Direct Bilirubin is a medical device that received FDA 510(k) clearance on 2016-02-16. The listed applicant is Randox Laboratories Limited. The 510(k) number is K152343.

When did Direct Bilirubin receive FDA 510(k) clearance?

Direct Bilirubin received FDA 510(k) clearance on 2016-02-16, under 510(k) number K152343.

Who is the listed applicant for Direct Bilirubin?

The FDA 510(k) record lists Randox Laboratories Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Direct Bilirubin?

The FDA product code for Direct Bilirubin is JFM.

列明Randox Laboratories Limited为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K250741Evidence MultiSTAT DOA尿液多联检测 K220451Evidence MultiSTAT DOA尿液多联检测，Evidence MultiSTAT K221550Evidence MultiSTAT DOA尿液多联检测 K162275Randox RX Daytona Plus 碱性磷酸酶 (ALP)K161691直接低密度脂蛋白胆固醇（LDL）K152344总胆红素

查看所有 7 个设备 →

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。